Literature DB >> 5272106

Evaluation of L-dopa therapy in Parkinson's disease.

R J Mones, T S Elizan, G J Siegel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5272106

Source DB:  PubMed          Journal:  N Y State J Med        ISSN： 0028-7628


× No keyword cloud information.
  8 in total

Review 1.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

2.  Treatment of Parkinson's syndrome with L-DOPA on an out-patient basis.

Authors:  C Fehling
Journal:  Z Neurol       Date:  1972

3.  Hypersexuality and limbic system seizures.

Authors:  O J Andy
Journal:  Pavlov J Biol Sci       Date:  1977 Oct-Dec

4.  Levodopa and orphenadrine hydrochloride in Parkinsonism.

Authors:  R K Whyte; K R Hunter; D R Laurence; G M Stern; P Armitage
Journal:  Eur J Clin Pharmacol       Date:  1971-12       Impact factor: 2.953

5.  What Is the Most Important and Impactful Paper Related to Movement Disorder Therapy Published in the 20th Century?

Authors:  Stanley Fahn
Journal:  Mov Disord Clin Pract       Date:  2021-09-21

6.  An analysis of six patients with Parkinson's disease who have been unresponsive to L-dopa therapy.

Authors:  R J Mones
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-06       Impact factor: 10.154

7.  Levodopa therapy of patients with Parkinsonism and heart disease.

Authors:  R B Jenkins; S H Mendelson; S Lamid; H L Klawans
Journal:  Br Med J       Date:  1972-08-26

8.  Analysis of L-dopa induced dyskinesias in 51 patients with Parkinsonism.

Authors:  R J Mones; T S Elizan; G J Siegel
Journal:  J Neurol Neurosurg Psychiatry       Date:  1971-12       Impact factor: 10.154
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.